2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

File Description SizeFormat 
ESC Cardio-Oncology Position Statement EHJ 2016.pdfPublished version1.19 MBAdobe PDFDownload
Title: 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Author(s): Zamorano, JL
Lancellotti, P
Rodriguez Muñoz, D
Aboyans, V
Asteggiano, R
Galderisi, M
Habib, G
Lenihan, DJ
Lip, GY
Lyon, AR
Lopez Fernandez, T
Mohty, D
Piepoli, MF
Tamargo, J
Torbicki, A
Suter, TM
Item Type: Journal Article
Publication Date: 26-Aug-2016
Date of Acceptance: 1-Aug-2016
URI: http://hdl.handle.net/10044/1/40176
DOI: https://dx.doi.org/10.1093/eurheartj/ehw211
ISSN: 1522-9645
Publisher: Oxford University Press
Start Page: 2768
End Page: 2801
Journal / Book Title: European Heart Journal
Volume: 37
Issue: 36
Copyright Statement: © The European Society of Cardiology 2016. All rights reserved.
Keywords: European Society of Cardiology
arrhythmias
cancer therapy
cardio-oncology
cardiotoxicity
chemotherapy
early detection
ischaemia
myocardial dysfunction
surveillance
Authors/Task Force Members
ESC Committee for Practice Guidelines (CPG):
Cardiovascular System & Hematology
1102 Cardiovascular Medicine And Haematology
Publication Status: Published
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons